Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 4

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(4)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06197399Not ApplicableNot Yet Recruiting

A Randomized Controlled Trial for Surgical Treatment of Recurrent Adult Tethered Cord Syndrome

Role: collaborator

NCT06082414Completed

Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants

Role: collaborator

NCT05987839Not ApplicableCompleted

Early Radiographic and Clinical Outcomes of Robotic-Arm-Assisted Versus Conventional TKA

Role: collaborator

NCT05947734Not ApplicableCompleted

Robot Assisted Total Hip Arthroplasties

Role: collaborator

NCT04711720Not ApplicableUnknown

A Randomized Controlled Trial for Patients Underwent Total Hip Arthroplasties Assisted by Surgical Navigation System

Role: collaborator

NCT03236636Phase 3Unknown

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Role: collaborator

NCT03890055Phase 4Unknown

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Role: lead

All 7 trials loaded